BLIJLEVENS N.

Last name: BLIJLEVENS N.

2022 (v1)

Publication

Metadata-only

HEV infection in stem cell transplant recipients—retrospective study of EBMT Infectious Diseases Working Party

Mikulska M. Penack O. Wendel L.

HEV infection is an emerging cause of acute and chronic hepatitis in stem cell transplant (SCT) recipients. We performed a retrospective observational study among EBMT centers with the aim of describing characteristics, management and outcome of HEV after SCT. There were 34 cases of HEV infection from 12 centers in 6 countries, diagnosed in...

Uploaded on: February 14, 2024
2019 (v1)

Publication

Metadata-only

The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT

Schmidt-Hieber M. Tridello G. Ljungman P.

It has been shown recently that donor and/or recipient cytomegalovirus (CMV) seropositivity is associated with a significant overall survival (OS) decline in acute leukemia patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT). We now analyzed the prognostic impact of the donor/recipient CMV serostatus in 6968...

Uploaded on: April 14, 2023
2021 (v1)

Publication

Metadata-only

Risk of infectious complications in adult patients after allogeneic hematopoietic stem cell transplantation depending on the site of central venous catheter insertion—multicenter prospective observational study, from the IDWP EBMT and Nurses Group of EBMT

Snarski E. Stringer J. Mikulska M.

The current guidelines for prevention of infections in hematopoietic stem cell transplantation (HSCT) do not specify which central venous catheter (CVC) insertion site should be preferred in allogeneic HSCT recipients—internal jugular vein (IJV) or subclavian vein (SCV). We designed a multicenter prospective observational study comparing the...

Uploaded on: February 14, 2024

BLIJLEVENS N.

Recent uploads